Foresite Capital Management III as of Dec. 31, 2017
Portfolio Holdings for Foresite Capital Management III
Foresite Capital Management III holds 17 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Aerie Pharmaceuticals | 32.7 | $117M | 2.0M | 59.75 | |
| Immunomedics | 12.2 | $44M | 2.7M | 16.16 | |
| Alder Biopharmaceuticals | 9.2 | $33M | 2.8M | 11.45 | |
| Blueprint Medicines (BPMC) | 8.5 | $30M | 400k | 75.41 | |
| Aimmune Therapeutics | 8.1 | $29M | 765k | 37.82 | |
| Achaogen | 7.2 | $26M | 2.4M | 10.74 | |
| Ascendis Pharma A S (ASND) | 3.8 | $14M | 336k | 40.06 | |
| Myokardia | 3.6 | $13M | 305k | 42.10 | |
| Epizyme | 3.5 | $13M | 998k | 12.55 | |
| Acceleron Pharma | 3.3 | $12M | 279k | 42.44 | |
| Verona Pharma Plc ads (VRNA) | 1.8 | $6.3M | 528k | 11.87 | |
| Wave Life Sciences (WVE) | 1.6 | $5.7M | 162k | 35.10 | |
| Cymabay Therapeutics | 1.6 | $5.5M | 600k | 9.20 | |
| Aclaris Therapeutics (ACRS) | 1.5 | $5.3M | 213k | 24.66 | |
| Biohaven Pharmaceutical Holding | 0.8 | $2.9M | 106k | 26.98 | |
| Tocagen | 0.4 | $1.5M | 149k | 10.25 | |
| Pacific Biosciences of California (PACB) | 0.3 | $1.2M | 448k | 2.64 |
